Metformin versus Insulin for the Treatment of Gestational Diabetes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. RESULTS: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 0.99 [corrected]; 95% confidence interval, 0.80 [corrected] to 1.23 [corrected]). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. CONCLUSIONS: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [73]
In the citing paper
“It was concluded that metformin alone, or with supplemental insulin, was not associated with increased perinatal complications.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [112]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [89]
In the citing paper
“Glyburide is effective in controlling blood glucose in women with gestational diabetes”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000
Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C., & Hedderson, M. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113623.18286.20 · Cited by 452
Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 430
Research works printed but not linked: 3
- Coetzee EJ, 1980, S Afr Med J, 58, 795
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Gutzin SJ, 2003, Can J Clin Pharmacol, 10, 179
Cited by
Items 701–800 of 1,001
Insulin Therapy in Gestational Diabetes
Stoian, A. P., Stoica, R. A., & Ștefan, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.84569 · Cited by 5
Could there be a role for metformin in type 1 and type 2 diabetic pregnancies?
Pernicova, I., Prasai, M. J., Close, E. J., Drury, K., Gilbey, S. G., Brewster, J. A., & SCOTT, E. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2256-8 · Cited by 5
“In gestational diabetes, the use of metformin has been associated with less weight gain in pregnancy without increased adverse outcomes [5, 6].”
BackgroundDiabetes Mellitus and Pregnancy
Szmuilowicz, E. D., Niznik, C. M., & Metzger, B. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64972-3 · Cited by 5
A Rational Method for Ranking Engineering Programs.
Glower, D. D. (1980) · Cited by 5
Yu, D., Xu, G., Teng, X., Xu, J., Tang, L., Feng, C., Rao, J., Jin, M., & Wang, L. (2021) · Research Square · doi:10.21203/rs.3.rs-146509/v1 · Cited by 5
Shah, M. K., Shah, M. A., Shah, S. D., Shah, P. K., Patel, K., & Gupta, M. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1319_21 · Cited by 6
Long-term effects of metformin use in gestational diabetes mellitus on offspring health
Roy, A., & Sahoo, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1812 · Cited by 5
Medications for Managing Preexisting and Gestational Diabetes in Pregnancy
Rickert, M. C., Caughey, A. B., & Valent, A. M. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2022.10.007 · Cited by 5
Ryan, L. W. K., Weiying, L., Wright, A., & Tan, L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009507189 · Cited by 4
Metformin and human uterine contractility
Hehir, M. P., & Morrison, J. J. (2012) · Endocrine · doi:10.1007/s12020-012-9687-y · Cited by 4
“Tight glycemic control during pregnancy has, however been shown to bring both fetal and maternal benefits in cases of type 1 and type 2 diabetes [2].”
BackgroundHashimoto, N., Yokoi, N., Komada, H., Matsuda, T., Hirota, Y., Sakaguchi, K., Takahashi, Y., Ogawa, W., & Seino, S. (2012) · Diabetology International · doi:10.1007/s13340-012-0079-6 · Cited by 4
Guidelines for the management of gestational diabetes in pregnancy
Glastras, S. J., & Fulcher, G. R. (2012) · Clinical Practice · doi:10.2217/cpr.12.9 · Cited by 7
Drug use in gestational diabetes
Fraser, R. B. (2009) · The British Journal of Diabetes · doi:10.1177/1474651408101374 · Cited by 4
Metformin in diabetic pregnancy
Swaminathan, K., Howlett, H., & Campbell, I. L. (2009) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520093901005 · Cited by 6
“25 Therefore metformin may have an adjunct role to insulin which may be important in those pregnant females with marked insulin resistance and who require very large insulin doses.”
InfluentialA comparative study of metformin and glyburide in gestational diabetes mellitus
Pujara, P., Singh, V., Murmu, S., Kumari, S., & Prajapati, D. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20171416 · Cited by 4
“3% of patientsreceiving metformin received supplemental insulin to achieve euglycemia.(19,20) Among maternal variables glycemic control of both groups were comparable.”
BackgroundReece, S. W., Parihar, H. S., & Martinez, M. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0002 · Cited by 8
Christian, S. J., Boama, V., Satti, H., Ramawat, J., Elhadd, T. A., Ashawesh, K., Dukhan, K., & Beer, S. F. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3540-1 · Cited by 7
Paul, P. G., Priyambada, L., Abraham, A., Manimegalai, B., Paul, T. V., Princy, S. F. X., Antonisamy, B., Thomas, N., Yenuberi, H., & Mathews, J. E. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13380 · Cited by 4
Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy
Shmuel, E., Krispin, E., Toledano, Y., Chen, R., Wiznitzer, A., & Hadar, E. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1875208 · Cited by 7
Tu, W., Zeng, Q., Wang, K., Wang, Y., Sun, B., Zeng, X., & Liu, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2027359 · Cited by 4
Diabetes in Pregnancy: Preconception to Postpartum
Healy, A. M. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.009 · Cited by 6
An Overview of Gestational Diabetes
Federico, C., & Pridjian, G. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00012-x · Cited by 4
Gerbier, E., Favre, G., Maisonneuve, É., Ceulemans, M., Winterfeld, U., Dao, K., Schmid, C., Jenkinson, S. P., Niżnik, B., Baud, D., et al. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4105993 · Cited by 6
“Although many of these women likely required an insulin switch to maintain optimal diabetes mellitus control, others might have been able to continue metformin and avoid certain constraints, including the need to learn/adapt to a new treatment, the risk of hypoglycemia and weight gain and the inconvenience/unpleasantn…”
BackgroundMethodMetformin ameliorates endometrial thickness in a rat model of thin endometrium
Imran, M. J., Khandvilkar, A., Metkari, S., Sachdeva, G., & Chaudhari, U. K. (2024) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13862 · Cited by 4
Maternal and Neonatal Outcomes in Patients of Gestational Diabetes Mellitus on Metformin Therapy
Gupta, S., Takkar, N., & Goel, P. (2019) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-019-01216-4 · Cited by 4
O impacto do uso da metformina para gestantes obesas na prevenção da pré-eclâmpsia
do Nascimento, I. B., Sales, W. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., & Silva, J. C. (2020) · Scientia Medica · doi:10.15448/1980-6108.2020.1.35338 · Cited by 5
Busta, A., Franco-Akel, A., Gurevich, Y., Schneider, A. E., & Rayfield, E. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_15 · Cited by 4
Shaffer, S. K., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.033 · Cited by 4
Wang, T., Jing, Y., Guo, H., Xu, J., Wang, M., Huang, L., Chen, H., Cui, W., Song, L., Liu, X., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980578 · Cited by 6
“However, for those who fail to control their blood glucose, hypoglycemic drugs should be used including insulin (6–8), metformin (6, 8), glyburide (7), and in some studies, acarbose (9).”
BackgroundBailey, C. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_8 · Cited by 4
TRATAMIENTO DE LA DIABETES EN EL EMBARAZO: ¿ALGO NUEVO?
Gloria López, S. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.04.014 · Cited by 5
Игоревна, С. А., Esayan, E. R. M., Игоревна, К. О., & Gardanova, Z. R. (2016) · Diabetes Mellitus · doi:10.14341/dm2004126-29 · Cited by 5
Second Trimester Pregnancy Loss
Casey, F. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.026 · Cited by 5
Neurodevelopmental Outcome in Offspring Born Following Gestational Diabetes
BATTIN, M. R., Wouldes, T. A., & Rowan, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_27 · Cited by 4
Self-citationTaylor, S. R. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.gdm_overview · Cited by 4
What's New in Obstetric Anesthesia: The 2009 Gerard W. Ostheimer Lecture
Sullivan, J. T. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c8513f · Cited by 4
“Two important recent studies addressed the management of gestational diabetes.(33,34) The first evaluated pregnancy outcomes associated with fasting maternal blood glucose levels that were increased but below the diagnostic threshold for gestational diabetes (75–105 mg/dL).”
BackgroundResultType 2 diabetes in pregnancy: importance of optimized care before, during and after pregnancy
Keely, E. (2008) · Obstetric Medicine · doi:10.1258/om.2008.080007 · Cited by 4
Disorders of carbohydrate metabolism in women with polycystic ovary syndrome (PCOS)
Dardzińska, J. A., Kuligowska-Jakubowska, M., & Rachoń, D. (2012) · Clinical Diabetology · Cited by 11
Toledano, Y., Hadar, E., & Hod, M. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch56 · Cited by 5
Gestational Diabetes: An Opportunity for Improvement
Ecker, J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2204 · Cited by 4
“What threshold should be used in defining GDM (1) and the benefits of (2) and best methods for treating GDM ( 3 , 4) continue to be mattersofongoinginvestigationanddebate.Thereshouldbeno debate,however,abouttherelationshipbetweenGDMandlater diabetes mellitus (DM).”
und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG )
Kellerer, M., Matthaei, S., Autoren, R. K., Kleinwechter, H. J., Schäfer-Graf, U. M., Bührer, C., Hoesli, I. M., Kainer, F., Kautzky‐Willer, A., Pawlowski, B., et al. (2011) · Cited by 4
Mahmoud, T. S. H., Mujaibel, K., Attia, H., Zakaria, Z., Yagan, J. A., Gheith, O. A. A., Halim, M. A., Nair, P. M., & Al-Otaibi, T. (2017) · Experimental and Clinical Transplantation · doi:10.6002/ect.mesot2016.p23 · Cited by 4
A Clinical Insight into Gestational Diabetes
Hh, S., Mahmood, T., Siddiqui, M. H., Bagga, P., Ahsan, F., & Shamim, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.85892 · Cited by 3
Dempsey, A., Mumby, C., Bernatavicius, G., Roberts, S. A., & Myers, J. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1852209 · Cited by 4
“A questionnaire based on that was successfully used in the MIG trial [11] to assess satisfaction, treatment compliance and acceptability.”
BackgroundMethodXie, E. F., Rodriguez, S. H., Xie, B., D’Souza, M., Gonnah, R., Sulakhe, D., & Skondra, D. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1151239 · Cited by 4
Ugwu, U. C., & Ene, O. C. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01252-x · Cited by 4
Garvey, Z., Gupta, A., Taylor, N., Thirunavukkarasu, M., & Maulik, N. (2025) · Metabolites · doi:10.3390/metabo15030180 · Cited by 4
“Other effects on neonatal outcomes observed in metformin trials include reduced incidence rates of low-for-gestational-age babies [79] and lower instances of hypoglycemia [80–82].”
Lu, Q. (2025) · American Journal of Translational Research · doi:10.62347/qjzn6645 · Cited by 3
Lachaud, A. E., & Durnwald, C. P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0148 · Cited by 3
D’Souza, A., Abdullahi, H., Badri, F., & Ibrahim, I. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07869-6 · Cited by 5
Nelson, S. M., & Poston, L. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782466.016 · Cited by 3
New Technologies for the Management of Pregestational Diabetes Mellitus
Lee-Parritz, A. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31824bb538 · Cited by 3
“A randomized controlled trial published in 2008 demonstrated equivalent neonatal outcomes with metformin compared with insulin for the treatment of gestational diabetes (GDM), although many women receiving metformin required supplemental insulin.(41) Metformin does have known gastrointestinal side effects, which can p…”
ResultUse of Oral Hypoglycemic and Insulin Agents in Pregnant Patients
Feldman, D. M., & Fang, Y. M. V. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.015 · Cited by 3
The Endocrine Society Diabetes and Pregnancy guidelines: a critical appraisal
Kalra, S., Gupta, Y., & Kalra, B. (2014) · Diabetic Medicine · doi:10.1111/dme.12520 · Cited by 3
Abnormal Glucose Metabolism: Diagnosis and Management in the Ambulatory Setting
HAWKINS, J. Z. S., & Wing, D. A. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31825cf731 · Cited by 4
Farrant, M. T., Williamson, K. A., BATTIN, M. R., Hague, W. M., & Rowan, J. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12518 · Cited by 3
Self-citationStewart, Z. A., & Murphy, H. R. (2014) · Medicine · doi:10.1016/j.mpmed.2014.10.010 · Cited by 11
Metformin use in gestational diabetes
Campbell, I. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00018-7 · Cited by 3
Daud, N. A. A., Mohiuddin, S. G., Ong, Y. P., Yusof, F. A. M., Yusoff, F., Harun, S. N., & Ghadzi, S. M. S. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_542_20 · Cited by 3
Wass, J., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0013 · Cited by 3
Mnatzaganian, G., Taylor, M., He, F., Yuen, N., McIntyre, D. H., Woodward, M., Ma, L., & Huxley, R. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2250005 · Cited by 4
“A number of trials have confirmed the safety of both insulin [39] and metformin [42,43] in pregnancy, and the positive impact they have on neonatal outcomes.”
BackgroundPandey, A. K., Naik, B., Uday, R., & Shivaprasad, C. (2024) · Cureus · doi:10.7759/cureus.61849 · Cited by 5
Neola, D., Angelino, A., Sirico, A., Murolo, C., Bartolini, G., Vigilante, L., Raffone, A., Carbone, L., Sarno, L., Saccone, G., et al. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15728 · Cited by 3
“The authors argued that gestational age at diabetes diagnosis and pretreatment made blood glucose an important factor, in contrast to the study by Rowan et al., 5 in which BMI and glycosylated hemoglobin (HbA 1c ) were supposed to be important factors.”
Romeo, P., D’Anna, R., & Corrado, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185387 · Cited by 4
Imada, T., Sasaki, S., Yamaguchi, H., Ueda, A., Kawamori, D., Katakami, N., & Shimomura, I. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14410 · Cited by 3
“Metformin use in pregnancy has evidence of not increasing congenital anomalies and perinatal complications 6 – 8 .”
Kretschmer, T., Turnwald, E., Thiele, A., Kallage, C., Neweling, L., Kammerer, M. D., Janoschek, R., Zentis, P., Handwerk, M., Wohlfarth, M., et al. (2025) · Placenta · doi:10.1016/j.placenta.2025.09.016 · Cited by 4
Clinical management of obesity in pregnancy
Chiswick, C. A., & Denison, F. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782466.019 · Cited by 3
Induction and Augmentation of Labor
Goldberg, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.004 · Cited by 3
Kumar, R., LOWE, J. M., Thompson-Hutchison, F., Steinberg, D. J., Shah, B. R., Lipscombe, L. L., & Halperin, I. J. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.06.005 · Cited by 3
Medical Nutrition Therapy for Special Groups with Diabetes Mellitus
Kızılgül, M., Mermer, M., & Uçan, B. (2018) · InTech eBooks · doi:10.5772/intechopen.70815 · Cited by 3
“Although randomized controlled trials demonstrated the efficacy and short-term safety of metformin [28, 29] and glyburide [30], long-term safety trials are still lacking for any oral drugs [31].”
BackgroundSchäfer-Graf, U. M., & Tan, S. (2022) · Der Gynäkologe · doi:10.1007/s00129-021-04894-2 · Cited by 3
Gupta, S., Saxena, U., Arora, R., Zutshi, V., & Aggarwal, R. (2022) · The New Indian Journal of OBGYN · doi:10.21276/obgyn.2022.8.2.17 · Cited by 3
Influence of Maternal Obesity on the Long-Term Health of Offspring
Johns, E. C., Stoye, D. Q., Liu, Y., & Reynolds, R. M. (2019) · Healthy ageing and longevity · doi:10.1007/978-3-030-24958-8_11 · Cited by 3
Elsaeed, U. A., Riad, R. I., Taher, A., Elnokeety, M. M., & Elanwary, S. (2022) · Bali Medical Journal · doi:10.15562/bmj.v11i3.3082 · Cited by 5
Developmental Origins of Health and Disease across Generations – Theory, Observation, Experiment
Gillman, M. W., Smith, G. D., Hanson, M. A., & Spencer, H. G. (2009) · KARGER eBooks · doi:10.1159/000221153 · Cited by 3
Treatment Considerations for Gestational Diabetes Mellitus and Long-Term Postpartum Options
Radenkovi, M. (2011) · InTech eBooks · doi:10.5772/21908 · Cited by 4
“It has been demonstrated that women requiring supplemental insulin had a higher body mass index and had higher baseline glucose levels (Rowan et al. 2008).”
BackgroundInfluentialMetformina y diabetes gestacional
Martín-Herrasti, J. M. S., Alcázar-Álvarez, L. S., Serrano-Berrones, M. Á., Tirado-Chávez, J., & Castro-Herrera, G. A. (2014) · Revista de especialidades m�dico-quir�rgicas · Cited by 8
Gestational Diabetes: Evidence-Based Screening, Diagnosis and Treatment
Amorim, M. M. R., & Katz, L. (2011) · InTech eBooks · doi:10.5772/23392 · Cited by 5
Mathiesen, E. R., & Damm, P. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02531.x · Cited by 3
Weigl, B. H., Zwisler, G., Peck, R. B., & Abu‐Haydar, E. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2008326 · Cited by 4
Metformin therapy for gestational diabetes mellitus: are we there yet?
Feig, D. S. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0969 · Cited by 3
Diagnosis and Medical Management of Gestational Diabetes
Kim, S. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.3.174 · Cited by 3
“3%에서 인슐린의 추 가 투여가 필요하였다[32].”
Antidiabétiques oraux et grossesse
Sénat, M. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30120-7 · Cited by 7
Ng, A. Y. T., Liu, A., & Nanan, R. K. H. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12974 · Cited by 3
“Other studies compared the effects of antihyperglycemics and insulin treatment.(17,33,34) There have been no studies on the influence of insulin use on outcomes of neonates who are delivered via caesarean section.”
BackgroundResultEfectos perinatales de la metformina en diabetes gestacional
Lopez-Reyes, A., Escobedo-Aguirre, F., Lugo-Cruz, M. P., Jaén-Vento, L. A., & Macías‐Amezcua, M. D. (2020) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2020.09.002 · Cited by 3
Diabetes Mellitus and Pregnancy
Metzger, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00045-7 · Cited by 4
The patient with diabetes mellitus
Oats, J. J. N. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.009 · Cited by 3
Treatment options of Adolescent Gestational Diabetes: Effect on Outcome
Jasim, S. K., Al-Momen, H. H., & Wahbi, M. A. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.4.3966 · Cited by 7
7. Management of hyperglycemia during pregnancy
(2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30015-1 · Cited by 3
Diabetes Mellitus and Pregnancy
Metzger, B. E., & PHELPS, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00146-5 · Cited by 4
Diagnosis and management of gestational diabetes mellitus
Oh, T. J. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.7.414 · Cited by 3
Are Oral Hypoglycemic Agents Contraindicated in Pregnancy!
Amin, M. R., Hossain, M. Z., Miah, M. T., Yasmin, R., Chowdhury, M. F. I., & Hoque, M. A. (1970) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v28i2.5376 · Cited by 3
van Hoorn, E. G. M., van Dijk, P. R., Prins, J. R., Lutgers, H. L., Hoogenberg, K., Erwich, J. J., & Kooy, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056282 · Cited by 4
Which oral hypoglycaemic for gestational diabetes?
Sacks, D. A. (2015) · BMJ · doi:10.1136/bmj.h177 · Cited by 3
Lau, S. M. (2012) · Diabetes Care · doi:10.2337/dc11-2241 · Cited by 3
Tieu, J., Coat, S., Hague, W. M., & Middleton, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007724 · Cited by 4
Self-citationAdvances in Oral Anti‐Diabetes Drugs in Pregnancy
Mukerji, G., & Feig, D. S. (2017) · A Practical Manual of Diabetes in Pregnancy · doi:10.1002/9781119043805.ch15 · Cited by 2
Busarira, M. O., Getlawi, O. H., Hawda, S. M., Falgosh, S. A., & Peela, J. R. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_168_21 · Cited by 3
“The route of administration of metformin is oral making it a preferable option to women with GDM. [13,14] A study comparing metformin and insulin has reported that there was no significant difference between the two groups concerning the method of delivery, reason for cesarean section, birth…”
Reproductive outcomes in female mice offspring due to maternal metformin treatment
Velázquez, C., Herrero, Y., Prost, K., Bordaquievich, M., Neira, M., Parborell, F., & Abramovich, D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123416 · Cited by 2
Yoshimura, K., Hirota, Y., Hamaguchi, T., Takeuchi, T., Takayoshi, T., Saito, S., Ueda, M., Nishikage, S., Yamamoto, A., Hashimoto, N., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70105 · Cited by 3
Metadata
- Authors
- Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Women's and Children's Hospital (AU)
- Auckland University of Technology (NZ)
- University of Auckland (NZ)
- Christchurch Hospital (NZ)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-08
- Volume
- 358
- Issue
- 19
- Pages
- 2003-2015
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2003621575
- Cited by
- 1,291
- References
- 33
- Citations by year
- 2026: 49 · 2025: 60 · 2024: 52 · 2023: 65 · 2022: 63 · 2021: 90 · 2020: 67 · 2019: 66 · 2018: 105 · 2017: 125 · 2016: 68 · 2015: 82 · 2014: 69 · 2013: 62 · 2012: 56
- FWCI
- 78.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, neonatal hypoglycemia, perinatal complications, maternal glycemic control, postpartum glucose tolerance, treatment acceptability, treatment preferences, neonatal respiratory distress, phototherapy
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Gestational Age, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Metformin, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Diabetes, Gestational, Patient Satisfaction, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.